Recombinant peptide-carrier allergy vaccine: Recombinant allergy vaccine consisting of a non-allergen-derived carrier molecule and non-allergenic peptides derived from the IgE binding sites of the allergen. This evidence concerns the gene IGHE and allergic disease.